SLC13A5 and metabolic disease: Studies in flies, worms, mice, and rats have made INDY a potential target that could be used in a clinical setting to alleviate some metabolic disorders such as NAFLD, Type 2 diabetes, insulin resistance, and even carcinogenesis.